The role of the sulfaguanidine molecular scaffold in drug design and development

被引:1
|
作者
Abulkhair, Hamada S. [1 ,2 ]
机构
[1] Al Azhar Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Nasr City 11884, Cairo, Egypt
[2] Horus Univ Egypt, Fac Pharm, Pharmaceut Chem Dept, New Damietta, Egypt
关键词
anticancer; antimicrobial; Medicinal Chemistry; sulfaguanidine; synthesis;
D O I
10.1002/ardp.202400802
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Developing new molecular entities is one of the most emerging research areas in the field of Medicinal Chemistry. Over the past few years, rigorous research has been conducted on sulfaguanidine-linked synthetic molecules because of their promising potential in several biological activities. Sulfaguanidine has been actively incorporated in the design of anticancer, antimicrobial, antidiabetic, antiparkinsonian, anti-inflammatory, and antiviral candidates. The construction of these effective candidates has adopted many chemical approaches. A number of the prepared compounds displayed promising results that merit further investigations for the development of new medications. This review summarizes the different chemical strategies and the reported activities for sulfaguanidine-linked synthetic molecules throughout 2020-2024.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] From drug design to drug development
    Dondio, GM
    SEMINARS IN ORGANIC SYNTHESIS, 2003, : 71 - 90
  • [42] The role of structure-based ligand design and molecular modelling in drug discovery
    Tollenaere, JP
    PHARMACY WORLD & SCIENCE, 1996, 18 (02): : 56 - 62
  • [43] Role of Aromatic Rings in the Molecular Recognition of Aminoglycoside Antibiotics: Implications for Drug Design
    Vacas, Tatiana
    Corzana, Francisco
    Jimenez-Oses, Gonzalo
    Gonzalez, Carlos
    Gomez, Ana M.
    Bastida, Agatha
    Revuelta, Julia
    Luis Asensio, Juan
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (34) : 12074 - 12090
  • [44] Porous Titanium Scaffold: A New Design for Controlled Drug Delivery
    Sadeghzade S.
    Amini Najafabadi R.
    Meysami M.
    Meysami A.
    Khodaei M.
    Isfahani T.
    Material Design and Processing Communications, 2023, 2023
  • [45] MOLECULAR MODELING IN DRUG DESIGN
    TOPLISS, JG
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (12) : 2229 - 2229
  • [46] MOLECULAR MODIFICATION IN DRUG DESIGN
    AUTERHOF.H
    ARCHIV DER PHARMAZIE UND BERICHTE DER DEUTSCHEN PHARMAZEUTISCHEN GESSELSCHAFT, 1965, 298 (02): : 143 - &
  • [47] Molecular modeling for drug design
    Metternich, R
    CHIMIA, 2000, 54 (1-2) : 35 - 36
  • [48] MOLECULAR TOXICOLOGY AND DRUG DESIGN
    VERMEULEN, NPE
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1986, 8 (06) : 331 - 331
  • [49] MOLECULAR MODIFICATION IN DRUG DESIGN
    DRAIN, D
    CHEMISTRY & INDUSTRY, 1965, (14) : 592 - &
  • [50] Molecular modelling and drug design
    Laguerre, Michel
    BULLETIN DU CANCER, 2007, 94 : F115 - F127